AGPAT2 anticorps (C-Term)
Aperçu rapide pour AGPAT2 anticorps (C-Term) (ABIN310613)
Antigène
Voir toutes AGPAT2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- LEAIPTSGLT AADVPALVDT CHRAMRTTFL HISKTPQENG ATAGSGVQPA
-
Homologie
- Human: 100%, Pig: 91%
-
Attributs du produit
- This is a rabbit polyclonal antibody against AGPAT2. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Protein A purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the C terminal region of human AGPAT2
-
-
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (AA 1-278) antibody
AGPAT2 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (AA 199-278) antibodyAGPAT2 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) antibodyAGPAT2 Reactivité: Humain, Souris WB, IF Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (AA 199-278) antibodyAGPAT2 Reactivité: Humain WB, IF Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (C-Term) antibodyAGPAT2 Reactivité: Humain, Boeuf (Vache), Chien, Cheval, Saccharomyces cerevisiae WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (AA 51-117) antibodyAGPAT2 Reactivité: Humain WB, ELISA Hôte: Souris Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (AA 1-278) antibodyAGPAT2 Reactivité: Humain WB Hôte: Souris Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (C-Term) antibodyAGPAT2 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (C-Term) antibodyAGPAT2 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
anti-1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) antibodyAGPAT2 Reactivité: Humain WB, EIA Hôte: Lapin Polyclonal unconjugated
-
-
Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
-
Commentaires
-
Antigen size: 246 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
Autre désignation
- AGPAT2
-
Sujet
-
AGPAT2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance.This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Alias Symbols: 1-AGPAT2, BSCL, BSCL1, LPAAB, LPAAT-beta
Protein Interaction Partner: ABCG8, PHRF1, PHF11, ANKRD28, SLC23A2, GMPS, UBC,
Protein Size: 246 -
Poids moléculaire
- 27 kDa
-
ID gène
- 10555
-
NCBI Accession
- NM_001012727, NP_001012745
-
UniProt
- Q5VUD3
Antigène
-
